A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)

Chinese People's Liberation Army General Hospital Fifth Medical Center, Beijing

Peking university People's Hospital, Beijing

Beijing Cancer Hospital, Beijing

First Hospital of Jilin University, Changchun

Affiliated Cancer Hospital of Harbin Medical University, Harbin

Cancer Hospital Affiliated to Fudan University, Shanghai

Jiangsu Provincial People's Hospital, Nanjing

The First Affiliated Hospital of Soochow University, Suzhou

Anhui Provincial Hospital, Hefei

Anhui Cancer Hospital, Hefei

Shandong Provincial Hospital, Jinan

Qilu Hospital of Shandong University, Jinan

Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin

Tianjin Cancer Hospital, Tianjin

Zhejiang University Medical School affiliated to the first Hospital, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Jiangxi Cancer Hospital, Nanchang

Union Hospital Affiliated to Fujian Medical University, Fuzhou

Hunan Cancer Hospital, Changsha

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Henan Provincial People's Hospital, Zhengzhou

Henan Cancer Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Sun Yat-sen University Cancer Center, Guangzhou

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

Nanfang Hospital, Southern Medical University, Guangzhou

Guangdong Provincial People's Hospital, Guangzhou

Affiliated Hospital of Guizhou Medical University, Guiyang

West China Hospital of Sichuan University, Chengdu

The Second Hospital of Lanzhou University, Lanzhou

The Fourth Hospital of Hebei Medical University, Shijiazhuang